Latest news
Recon: BMS plans $2.3B Houston manufacturing site; MHRA approves Lilly weight-loss drug for weight loss, type 2 diabetes - RAPSRAPS · Mon, 10 Aug 2026 20:19:00 GMTSionna’s experimental cystic fibrosis pill falls flat in mid-stage trial - STATSTAT · Mon, 10 Aug 2026 15:34:15 GMTFDA panel to weigh Grail’s Galleri test - STATSTAT · Mon, 10 Aug 2026 14:49:08 GMTHeart failure drug from Tenax Therapeutics fails in pivotal study - STATSTAT · Mon, 10 Aug 2026 11:43:53 GMTSilence Therapeutics aims at Takeda with new data in rare blood cancer - STATSTAT · Mon, 10 Aug 2026 11:33:33 GMTSilence Therapeutics (SLN) halves losses and funds operations into 2028 in Q2 update - Stock TitanStock Titan · Mon, 10 Aug 2026 11:26:59 GMTThe promise of radiopharmaceuticals smacks into safety concerns - STATSTAT · Mon, 10 Aug 2026 08:33:33 GMTSilence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera - Yahoo! Finance CanadaYahoo! Finance Canada · Sun, 09 Aug 2026 21:00:00 GMT